We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.50 | 1.65% | 216.00 | 214.50 | 216.00 | 225.00 | 211.00 | 219.00 | 522,925 | 15:35:50 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Home Health Care Services | 23.75M | -50.35M | -0.1839 | -11.88 | 598.4M |
From Apr 2022 to Apr 2024
TIDMPRTC
RNS Number : 7517N
PureTech Health PLC
25 January 2023
25 January 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.
Date of purchase: 24 January 2023 Number of ordinary shares purchased: 842 Highest price paid per share: 264.00p Lowest price paid per share: 260.00p Volume weighted average price paid per share: 261.79p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 10,596,189 ordinary shares in treasury and has 278,871,970 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 278 ,871,970 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.
About PureTech Health
PureTech is a biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 26 therapeutics and therapeutic candidates, including two (Plenity(R) and EndeavorRx(R)) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that will soon be filed for FDA approval, as of the most recent update by the Company. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.
For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Hot Features
Premium
Transaction Transaction Volume Price Platform Transaction Reference
Date Time (GBp) Number
24/01/2023 09:44:20 3 264 TRQX 00335937430TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:41:34 3 264 TRQX 00335936487TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:37:52 78 263.5 XLON 00335935713TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:37:26 11 263 CHIX 00335935640TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:36:15 6 261.5 AQXE 00335935253TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:35:10 9 261 BATE 00335934960TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:34:20 3 263 TRQX 00335934813TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:34:03 89 261.5 XLON 00335934760TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:31:41 12 262 CHIX 00335934023TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:31:41 87 261.5 XLON 00335934022TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:30:06 3 263 TRQX 00335933527TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:29:24 6 262.5 AQXE 00335933132TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:29:04 12 262 BATE 00335933024TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:18:14 7 261 AQXE 00335926753TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:18:13 12 262 BATE 00335926745TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:18:13 3 263 TRQX 00335926746TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:17:29 5 261.5 AQXE 00335926117TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:17:28 12 262 CHIX 00335926091TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:10:25 91 262 XLON 00335921087TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:10:25 91 262 XLON 00335921086TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:06:17 3 263 TRQX 00335919790TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:05:20 172 260 XLON 00335919638TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:04:18 3 263 TRQX 00335919153TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:04:18 9 263 TRQX 00335919154TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:04:18 18 263 AQXE 00335919151TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:04:18 6 263 AQXE 00335919152TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:03:24 33 263 BATE 00335918996TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:03:24 11 263 BATE 00335918995TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:03:24 20 263 CHIX 00335918992TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:03:24 12 263 CHIX 00335918991TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:02:42 1 263 CHIX 00335918853TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:02:42 6 263 CHIX 00335918852TRLO1.1.1
------------ ------- ------- --------- ----------------------
24/01/2023 09:02:34 5 263 CHIX 00335918814TRLO1.1.1
------------ ------- ------- --------- ----------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSFFFFILFISFIV
(END) Dow Jones Newswires
January 25, 2023 02:00 ET (07:00 GMT)
1 Year Puretech Health Chart |
1 Month Puretech Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
